Laird Norton Trust Company, LLC Bristol Myers Squibb CO Transaction History

Laird Norton Trust Company, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $239,748 - $283,896	3,501 New	3,501 $251,000
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $193,822 - $213,466	-2,669 Reduced 32.3%	5,593 $433,000
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $10,943 - $13,122	-178 Reduced 2.11%	8,262 $603,000
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $5,792 - $6,752	108 Added 1.3%	8,440 $526,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $8,520 - $9,980	-144 Reduced 1.7%	8,332 $493,000
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $80,111 - $87,241	-1,294 Reduced 13.24%	8,476 $566,000
Q4 2020 Feb 26, 2021	BUY	$57.74 - $65.43 $564,119 - $639,251	9,770 New	9,770 $606,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Laird Norton Trust Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Laird Norton Trust Company, LLC with notifications on news.